Join the Epidiolex group to help and get support from people like you.
Epidiolex News (Page 3)
Vaping Cannabidiol Fairly Common Among Teens
MONDAY, Aug. 21, 2023 – Vaping cannabidiol (CBD) is common among U.S. teens, according to a study published online Aug. 16 in JAMA Network Open. Hongying Daisy Dai, Ph.D., from University of...
CBD Vapes Rising in Popularity Among Teens
THURSDAY, Aug. 17, 2023 – Vaping CBD (cannabidiol) is on the rise among middle and high school students, according to a national U.S. survey, and health experts warn there can be serious risks...
With Marijuana's Legalization, Cannabis Poisonings Are on the Rise
THURSDAY, July 27, 2023 – In recent years, the legalization of both medical and recreational marijuana has become the new normal across much of North America. The problem: New research finds that as...
FDA Sends Warning to Companies Selling THC Products That Look Like Candy, Cookies
THURSDAY, July 6, 2023 – Several companies are selling copycat food items that have the potential to trick people, including children, into consuming dangerous quantities of cannabis. On Wednesday,...
FDA Sends Warning to Companies Selling THC Products That Look Like Candy, Cookies
WEDNESDAY, July 5, 2023 – Several companies are selling copycat food items that have the potential to trick people, including children, into consuming dangerous quantities of cannabis. On Wednesday...
FDA Approves Epidiolex (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex
CARLSBAD, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) – GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines,...
FDA Medwatch Alert: FDA, FTC Warn Company Marketing Unapproved Cannabidiol Products with Unsubstantiated Claims to Treat Teething and Ear Pain in Infants, Autism, ADHD, Parkinson’s and Alzheimer’s Disease
October 22, 2019 – Today, the U.S. Food and Drug Administration and the Federal Trade Commission posted a joint warning letter to Rooted Apothecary LLC, of Naples, Florida, for illegally selling...
FDA Approves Epidiolex (cannabidiol) to Treat Lennox-Gastaut Syndrome and Dravet Syndrome
June 25, 2018 – The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy,...
Ask a question
To post your own question to this support group, sign in or create an account.